COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
10 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Aug. 13, 2026 |
Jun. 30, 2026 |
Jun. 05, 2026 |
Jun. 12, 2025 |
Mar. 31, 2026 |
Mar. 24, 2026 |
Jun. 10, 2025 |
Jun. 06, 2025 |
|
| Common stock par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||
| Authorized capital | ||||||||
| Zoar Labs Limited [Member] | ||||||||
| Authorized capital | $ 50,000 | |||||||
| Number of shares issued | 500,000,000 | |||||||
| Share price | $ 0.0001 | |||||||
| Contribution of ownership interests description | Following the formation of Zoar Labs Limited and execution of the Merger Agreement, on July 7, 2025, the DA Shareholder, as sole shareholder of Zoar HK Limited (then known as Dr Ashleys Limited), a Hong Kong registered company (the “HK Sub”), entered into a Sale and Purchase Agreement with Zoar Labs Limited, pursuant to which he contributed 100% of his shareholding in the capital of the HK Sub to Zoar Labs Limited, in exchange for the issuance of 99 ordinary shares of Zoar Labs Limited, par value $0.0001 per share, to the DA Shareholder. As a result of the contribution, the HK Sub became a wholly owned subsidiary of Zoar Labs Limited, and the DA Shareholder owned 100 ordinary shares of Zoar Labs Limited, par value $0.0001 per share. | |||||||
| Merger Agreement [Member] | ||||||||
| Common stock par value | 0.0001 | |||||||
| Merger Agreement [Member] | Zoar Labs Limited [Member] | ||||||||
| Common stock par value | $ 0.0001 | |||||||
| Repayment Agreement [Member] | ||||||||
| Accrued but unpaid principal, fees and charges outstanding | $ 8,000,000 | |||||||
| Number of shares issued | $ 1,334,000 | |||||||
| Stockholders equity description | Upon listing, the charged PubCo Shares are required to maintain a minimum aggregate market value of at least $8,000,000. If the aggregate market value of the charged PubCo Shares falls below $6,000,000, additional shares are required to be charged to restore the aggregate market value to at least $8,000,000. | |||||||
| Common Stock [Member] | ||||||||
| Authorized capital | $ 0 | |||||||
| Number of shares issued | 1 | |||||||
| Common Stock [Member] | June 2026 Amendment [Member] | ||||||||
| Share consideration | 168,076,000 | |||||||
| Percentage of shares issued and outstanding | 93.38% | |||||||
| Common Stock [Member] | June 2026 Amendment [Member] | DSS Inc [Member] | ||||||||
| Share consideration | 128,000 | |||||||
| Common Stock [Member] | June 2026 Amendment [Member] | Chief Executive Officer [Member] | ||||||||
| Share consideration | 22,000 | |||||||
| Common Stock [Member] | August 2026 Amendment [Member] | Subsequent Event [Member] | ||||||||
| Share consideration | 167,976,000 | |||||||
| Percentage of shares issued and outstanding | 93.32% | |||||||
| Common Stock [Member] | August 2026 Amendment [Member] | DSS Inc [Member] | Subsequent Event [Member] | ||||||||
| Share consideration | 228,000 |